ConductScience.org, home

Paper134464

The anticoagulant effect of heparan sulfate and dermatan sulfate.

Teien AN and 2 others. Thromb Res, 1976. Cited by 234 papers, by iCite.

Cite this record

ConductScience Library. The anticoagulant effect of heparan sulfate and dermatan sulfate. Papers, record 134464. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/134464

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
The anticoagulant effect of heparan sulfate and dermatan sulfate.
PubMed
Journal
Thromb Res
PubMed
Year
1976
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
234
iCite
Relative citation ratio, by iCite
8.03
iCite
Revised in PubMed
2026-01-28
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Teien ANA N
2Abildgaard UU
3Höök MM

Source PubMed

Download CSV of authors

Topics16

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Blood CoagulationMajor topic
ChondroitinMajor topic
Dermatan SulfateMajor topic
GlycosaminoglycansMajor topic
Heparan SulfateMajor topic
Animals
Antithrombins
Chondroitin Sulfates
Dose-Response Relationship, Drug
Factor X
Heparin
Humans
Hyaluronic Acid
Keratan Sulfate
Thrombin
Thromboplastin

Source PubMed

Download CSV of topics

Cited by32

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 234 citations.

PMIDTitleJournalYearIn PapersSource
41012547Targeting the Oral Mucosa: Emerging Drug Delivery Platforms and the Therapeutic Potential of Glycosaminoglycans.Pharmaceutics2025https://conductscience.org/library/papers/41012547PubMed
40705086The Role of Heparan Sulfate in Bone Repair and Regeneration.Calcif Tissue Int2025https://conductscience.org/library/papers/40705086PubMed
35518950The neutralization of heparan sulfate by heparin-binding copolymer as a potential therapeutic target.RSC Adv2019https://conductscience.org/library/papers/35518950PubMed
34410575COVID-19: the CaMKII-like system of S protein drives membrane fusion and induces syncytial multinucleated giant cells.Immunol Res2021https://conductscience.org/library/papers/34410575PubMed
33865880Antiviral strategies should focus on stimulating the biosynthesis of heparan sulfates, not their inhibition.Life Sci2021https://conductscience.org/library/papers/33865880PubMed
33729108De novo transcriptome reveals blood coagulation/antithrombin factors and infection mechanisms in Angiostrongylus cantonensis adult worms.Parasitology2021https://conductscience.org/library/papers/33729108PubMed
32377957Circulating heparan sulfate chains and body weight contribute to anti-Xa levels in cancer patients using the prophylactic dose of enoxaparin.J Thromb Thrombolysis2020https://conductscience.org/library/papers/32377957PubMed
26861358Marine Origin Polysaccharides in Drug Delivery Systems.Mar Drugs2016https://conductscience.org/library/papers/26861358PubMed
21152191Mesoglycan: clinical evidences for use in vascular diseases.Int J Vasc Med2010https://conductscience.org/library/papers/21152191PubMed
19102516Factors associated with bleeding in elderly hospitalized patients treated with enoxaparin sodium : a prospective, open-label, observational study.Drugs Aging2009https://conductscience.org/library/papers/19102516PubMed
18281504Vascular dermatan sulfate regulates the antithrombotic activity of heparin cofactor II.Blood2008https://conductscience.org/library/papers/18281504PubMed
17878401Accelerated atherogenesis and neointima formation in heparin cofactor II deficient mice.Blood2007https://conductscience.org/library/papers/17878401PubMed
16339402Placental dermatan sulfate: isolation, anticoagulant activity, and association with heparin cofactor II.Blood2006https://conductscience.org/library/papers/16339402PubMed
8136018Interaction of thrombin with antithrombin, heparin cofactor II, and protein C inhibitor.J Protein Chem1993https://conductscience.org/library/papers/8136018PubMed
7492320Effects of aging on the synthesis of antithrombin-binding sites on heparin chains and heparan sulphate chains in the rat.Biochem J1995https://conductscience.org/library/papers/7492320PubMed
7378640Evidence for antithrombin III involvement in the anticoagulant activity of cellulose sulphate.Br J Pharmacol1980https://conductscience.org/library/papers/7378640PubMed
7225714The anticoagulant activity of dermatan sulphates: evidence against the involvement of antithrombin III.Br J Pharmacol1981https://conductscience.org/library/papers/7225714PubMed
6802163The anticoagulant effect of chondroitin sulphates isolated from normal and atherosclerotic regions of human aortas.Br J Exp Pathol1982https://conductscience.org/library/papers/6802163PubMed
6508733Studies in vitro on the uptake and degradation of sodium hyaluronate in rat liver endothelial cells.Biochem J1984https://conductscience.org/library/papers/6508733PubMed
6452123Interaction of lipoprotein lipase with native and modified heparin-like polysaccharides.Biochem J1980https://conductscience.org/library/papers/6452123PubMed

See all 32 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/134464

GET https://conductscience.org/api/papers/v1/134464/cited_by?page=2